Evidence map›Paper›PMID 35707227›Full record

ArticleGMS hygiene and infection control2022

ESBL production and carbapenem resistance increased the secondary bloodstream infection rates in intensive care units in Turkey, 2014-2019.

Can Huseyin Hekimoglu, Serap Suzuk Yildiz, Selda Sahan, Esen Batir, Emine Yildirim Gozel, Dilek Altun, Gulen Pehlivanturk, Muhammet Comce, Fatih Kara

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in GMS hygiene and infection control, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Can Huseyin HekimogluMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, Turkey.
Serap Suzuk YildizMinistry of Health, General Directorate of Public Health, Department of Microbiology Reference Laboratory and Biological Products, Ankara, Turkey.
Selda SahanMinistry of Health, General Directorate of Public Health, Department of Tuberculosis, Ankara, Turkey.
Esen BatirMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, Turkey.
Emine Yildirim GozelMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, Turkey.
Dilek AltunMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, Turkey.
Gulen PehlivanturkMinistry of Health, General Directorate of Public Health, Department of Communicable Diseases, Ankara, Turkey.
Muhammet ComceMinistry of Health, General Directorate of Public Health, Ankara, Turkey.
Fatih KaraMinistry of Health, General Directorate of Public Health, Ankara, Turkey.
Ministry of Health · TRGeneral Directorate of Agricultural Research and Policies · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: Secondary bloodstream infections (SBSIs) are caused by another infection and differ from primary bloodstream infections (PBSIs) in terms of prevention and treatment strategies. The aim of this study was to determine the risk factors for bloodstream infections which were secondary to the most common healthcare-associated infections caused by the most common microorganisms in intensive care units (ICUs) and to examine whether extended-spectrum beta lactamase (ESBL) production and carbapenem resistance is related to the higher risk or not. Methods: The study population consisted of patients in ICUs with ventilator-associated pneumonia (VAP), ventilator-associated event (VAE) or catheter-associated urinary tract infection (CAUTI) caused by Results: Microorganism, ICU type, bed capasity and carbapenem resistance were found to be risk factors for SBSI for both types of infection. For VAPs/VAEs, female gender and hospital type were also identified as risk factors. The highest risk was in Discussion: By using the risk factors, it may be possible to recognize SBSIs earlier, especially in patients with CAUTIs or VAPs/VAEs caused by carbapenem-resistant or ESBL-producing

Indexed as

carbapenem resistancecatheter-associated urinary tract infectionextended spectrum beta-lactamasesecondary bloodstream infectionventilator-associated eventventilator-associated pneumonia

Identifiers

PMID35707227
PMCPMC9174877
OpenAlexW4285740613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.